Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of ABIO 12/01 (CKPV dimer) vaginal gel vs miconazole in vulvovaginal candidiasis
2005-001360-31Phase 2Completed
- Sponsor
- Abiogen Pharma
- Start
- Aug 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CKPV dimer in vulvovaginal candidiasis (VVC) (4 arms), sponsored by Abiogen Pharma. Primary endpoints: Safety and tolerability of ABIO 12/01 vaginal gel and Efficacy of ABIO 12/01 vaginal gel. Started Aug 2005; status: completed.
02
Drugs
CKPV dimer
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2005-001360-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001360-31.